Virus:Article Title: A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to inhibit infection and lung injury.
Article Snippet: .. A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to 1 inhibit infection and lung injury 2 Jady Liang1,2, Yu Onodera1,3, Yuchong Li1,4, Jianfeng Wu1,5, Sarah McColman1,6, David 3 T. Cramb6, Julie Khang1, Aye Aye Khine1, Ya-Wen Chen7, Ori D. Rotstein1,8, Samira 4 Mubareka9, Arthur S. Slutsky1,4,10, Haibo Zhang1,2,4,10,11 5 6 1Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Unity Health 7 Toronto, Toronto, ON, Canada 8 2Department of Physiology, University of Toronto, Toronto, ON, Canada 9 3Department of Emergency and Critical Care Medicine, Faculty of Medicine, Yamagata 10 University, Yamagata, Japan 11 4The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory 12 Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 13 China 14 5Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen 15 University, Guangzhou, Guangdong, China 16 6Department of Chemistry and Biology, Faculty of Science, Toronto Metropolitan 17 University, Toronto, ON, Canada 18 7Black Family Stem Cell Institute, Department of Cell, Developmental and Regenerative 19 Biology, Icahn School of Medicine at Mount Sinai, New York, USA 20 8Department of Surgery, University of Toronto, Toronto, ON, Canada 21 9Department of Medical Microbiology and Infectious Disease, Sunnybrook Health 22 Science Centre, Toronto, ON, Canada 23 10Interdepartmental Division of Critical Care Medicine, University of Toronto, ON, 24 Canada 25 11Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada 26 27 28 29 correspondence: haibo.zhang@unityhealth.to, orcid:0000-0002-1714-3038 ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS 30 Abstract 31 Background 32 The rapid emergence of highly transmissible and immune-evasive SARS-CoV-2 33 variants, including Omicron lineage strains, has reduced the effectiveness of existing 34 vaccines and antiviral therapies. ..
Infection:Article Title: A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to inhibit infection and lung injury.
Article Snippet: .. A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to 1 inhibit infection and lung injury 2 Jady Liang1,2, Yu Onodera1,3, Yuchong Li1,4, Jianfeng Wu1,5, Sarah McColman1,6, David 3 T. Cramb6, Julie Khang1, Aye Aye Khine1, Ya-Wen Chen7, Ori D. Rotstein1,8, Samira 4 Mubareka9, Arthur S. Slutsky1,4,10, Haibo Zhang1,2,4,10,11 5 6 1Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Unity Health 7 Toronto, Toronto, ON, Canada 8 2Department of Physiology, University of Toronto, Toronto, ON, Canada 9 3Department of Emergency and Critical Care Medicine, Faculty of Medicine, Yamagata 10 University, Yamagata, Japan 11 4The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory 12 Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 13 China 14 5Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen 15 University, Guangzhou, Guangdong, China 16 6Department of Chemistry and Biology, Faculty of Science, Toronto Metropolitan 17 University, Toronto, ON, Canada 18 7Black Family Stem Cell Institute, Department of Cell, Developmental and Regenerative 19 Biology, Icahn School of Medicine at Mount Sinai, New York, USA 20 8Department of Surgery, University of Toronto, Toronto, ON, Canada 21 9Department of Medical Microbiology and Infectious Disease, Sunnybrook Health 22 Science Centre, Toronto, ON, Canada 23 10Interdepartmental Division of Critical Care Medicine, University of Toronto, ON, 24 Canada 25 11Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada 26 27 28 29 correspondence: haibo.zhang@unityhealth.to, orcid:0000-0002-1714-3038 ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS 30 Abstract 31 Background 32 The rapid emergence of highly transmissible and immune-evasive SARS-CoV-2 33 variants, including Omicron lineage strains, has reduced the effectiveness of existing 34 vaccines and antiviral therapies. ..
Vaccines:Article Title: A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to inhibit infection and lung injury.
Article Snippet: .. A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to 1 inhibit infection and lung injury 2 Jady Liang1,2, Yu Onodera1,3, Yuchong Li1,4, Jianfeng Wu1,5, Sarah McColman1,6, David 3 T. Cramb6, Julie Khang1, Aye Aye Khine1, Ya-Wen Chen7, Ori D. Rotstein1,8, Samira 4 Mubareka9, Arthur S. Slutsky1,4,10, Haibo Zhang1,2,4,10,11 5 6 1Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Unity Health 7 Toronto, Toronto, ON, Canada 8 2Department of Physiology, University of Toronto, Toronto, ON, Canada 9 3Department of Emergency and Critical Care Medicine, Faculty of Medicine, Yamagata 10 University, Yamagata, Japan 11 4The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory 12 Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 13 China 14 5Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen 15 University, Guangzhou, Guangdong, China 16 6Department of Chemistry and Biology, Faculty of Science, Toronto Metropolitan 17 University, Toronto, ON, Canada 18 7Black Family Stem Cell Institute, Department of Cell, Developmental and Regenerative 19 Biology, Icahn School of Medicine at Mount Sinai, New York, USA 20 8Department of Surgery, University of Toronto, Toronto, ON, Canada 21 9Department of Medical Microbiology and Infectious Disease, Sunnybrook Health 22 Science Centre, Toronto, ON, Canada 23 10Interdepartmental Division of Critical Care Medicine, University of Toronto, ON, 24 Canada 25 11Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada 26 27 28 29 correspondence: haibo.zhang@unityhealth.to, orcid:0000-0002-1714-3038 ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS 30 Abstract 31 Background 32 The rapid emergence of highly transmissible and immune-evasive SARS-CoV-2 33 variants, including Omicron lineage strains, has reduced the effectiveness of existing 34 vaccines and antiviral therapies. ..
|